comparemela.com
  1. Home
  2. Live Updates
  3. Company Loss - Breaking News

Page 14 - Company Loss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter.

Blaise colemanPrnewswire endo internationalBranded pharmaceuticalsCompany net debt leverage ratioPaladin labs incGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalNevakar injectables incCompany lossBranded specialty productsChief executiveMonths ended march

Endo International plc: ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

DUBLIN, May 5, 2022 /PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022 financial

Blaise colemanPrnewswire endo internationalBranded pharmaceuticalsCompany net debt leverage ratioPaladin labs incGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalNevakar injectables incCompany lossBranded specialty productsChief executiveMonths ended march

ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

DUBLIN, May 5, 2022 /PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2.

Blaise colemanPrnewswire endo internationalBranded pharmaceuticalsPaladin labs incCompany net debt leverage ratioGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalNevakar injectables incCompany lossBranded specialty productsChief executiveMonths ended march

ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter.

Blaise colemanPrnewswire endo internationalBranded pharmaceuticalsCompany net debt leverage ratioPaladin labs incGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalNevakar injectables incCompany lossBranded specialty productsChief executiveMonths ended march

ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS

/PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and.

New yorkUnited statesChestnut ridgeBlaise colemanCompany netBranded pharmaceuticalsCompany net debt leverage ratioGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalCompany lossChief executive officerMonths ended december

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.